Tumor microenvironment
31 – 40 of 1968
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Endosomal escape of RNA therapeutics
(2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
- Contribution to journal › Article
-
Mark
Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients
- Contribution to journal › Article
-
Mark
Tumor suppressor role of the complement inhibitor CSMD1 and its role in TNF-induced neuroinflammation in gliomas
- Contribution to journal › Article
-
Mark
Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer
- Contribution to journal › Article
-
Mark
Treatment with BRAF/MEK : inhibitors in mutant BRAF V600E papillary craniopharyngioma
- Contribution to journal › Article
-
Mark
Beyond HRD Status : Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian Cancer
- Contribution to journal › Article
-
Mark
Decoding of the surfaceome and endocytome in primary glioblastoma cells identifies potential target antigens in the hypoxic tumor niche
- Contribution to journal › Article
- 2023
-
Mark
Endogenous incretin levels and risk of first incident cancer: a prospective cohort study
- Contribution to journal › Article
-
Mark
Analysis of Extracellular Vesicle-Associated Proteoglycans
- Contribution to journal › Article
